Search Results

There are 10992 results for: content related to: The Role of the Clinical Nurse Specialist in the Assessment and Management of Biologic Therapies

  1. You have free access to this content
    Etanercept for the treatment of rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Anne Lethaby, Maria Angeles Lopez-Olivo, Lara J Maxwell, Amanda Burls, Peter Tugwell and George A Wells

    Published Online : 31 MAY 2013, DOI: 10.1002/14651858.CD004525.pub2

  2. Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Ahmed Kotb, Robin Christensen, Amy S Mudano, Lara J Maxwell, Nipam P Shah, Peter Tugwell and George A Wells

    Published Online : 13 MAY 2016, DOI: 10.1002/14651858.CD012183

  3. Tocilizumab for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Jasvinder A Singh, Saba Beg and Maria Angeles Lopez-Olivo

    Published Online : 7 JUL 2010, DOI: 10.1002/14651858.CD008331.pub2

  4. Biologics for rheumatoid arthritis: an overview of Cochrane reviews

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Robin Christensen, George A Wells, Maria E Suarez-Almazor, Rachelle Buchbinder, Maria Angeles Lopez-Olivo, Elizabeth Tanjong Ghogomu and Peter Tugwell

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD007848.pub2

  5. You have free access to this content
    Predictors of Stopping and Starting Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis

    Arthritis Care & Research

    Volume 66, Issue 8, August 2014, Pages: 1152–1158, Daniel H. Solomon, Chris Tonner, Bing Lu, Seoyoung C. Kim, John Z. Ayanian, M. Alan Brookhart, Jeffrey N. Katz and Ed Yelin

    Version of Record online : 28 JUL 2014, DOI: 10.1002/acr.22286

  6. Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Wanruchada Katchamart, Judith Trudeau, Veerapong Phumethum and Claire Bombardier

    Published Online : 14 APR 2010, DOI: 10.1002/14651858.CD008495

  7. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Glen S Hazlewood, Cheryl Barnabe, George Tomlinson, Deborah Marshall, Daniel JA Devoe and Claire Bombardier

    Published Online : 29 AUG 2016, DOI: 10.1002/14651858.CD010227.pub2

  8. You have free access to this content
    Use and Spending for Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among US Medicare Beneficiaries

    Arthritis Care & Research

    Volume 67, Issue 9, September 2015, Pages: 1210–1218, Jinoos Yazdany, Chris Tonner and Gabriela Schmajuk

    Version of Record online : 26 AUG 2015, DOI: 10.1002/acr.22580

  9. You have full text access to this OnlineOpen article
    Frequency and trends of disease-modifying antirheumatic drug (DMARD) use in Germany

    Pharmacology Research & Perspectives

    Volume 4, Issue 5, October 2016, Alexander M. Fassmer, Edeltraut Garbe and Niklas Schmedt

    Version of Record online : 27 SEP 2016, DOI: 10.1002/prp2.254

  10. Patterns of Disease-Modifying Antirheumatic Drug Use, Medical Resource Consumption, and Cost Among Rheumatoid Arthritis Patients

    Therapeutic Apheresis

    Volume 5, Issue 2, April 2001, Pages: 92–104, Robert I. Griffiths, Miriam Bar-Din, Catherine MacLean, Erin M. Sullivan, Robert J. Herbert and Edward H. Yelin

    Version of Record online : 21 DEC 2001, DOI: 10.1046/j.1526-0968.2001.005002092.x

  11. You have free access to this content
    Patterns of Disease-Modifying Antirheumatic Drug Use in Rheumatoid Arthritis Patients After 2002: A Systematic Review

    Arthritis Care & Research

    Volume 65, Issue 12, December 2013, Pages: 1927–1935, Gabriela Schmajuk, Daniel H. Solomon and Jinoos Yazdany

    Version of Record online : 27 NOV 2013, DOI: 10.1002/acr.22084

  12. You have free access to this content
    Patients' Considerations in the Decision-Making Process of Initiating Disease-Modifying Antirheumatic Drugs

    Arthritis Care & Research

    Volume 67, Issue 7, July 2015, Pages: 956–964, Ingrid Nota, Constance H. C. Drossaert, Erik Taal and Mart A. F. J. van de Laar

    Version of Record online : 25 JUN 2015, DOI: 10.1002/acr.22531

  13. You have free access to this content
    Relationships Between Driving Distance, Rheumatoid Arthritis Diagnosis, and Disease-Modifying Antirheumatic Drug Receipt

    Arthritis Care & Research

    Volume 66, Issue 11, November 2014, Pages: 1634–1643, Jennifer M. Polinski, M. Alan Brookhart, John Z. Ayanian, Jeffrey N. Katz, Seoyoung C. Kim, Joyce Lii, Chris Tonner, Edward Yelin and Daniel H. Solomon

    Version of Record online : 24 OCT 2014, DOI: 10.1002/acr.22333

  14. You have free access to this content
    Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: Five-year experience from the FIN-RACo study

    Arthritis & Rheumatism

    Volume 50, Issue 7, July 2004, Pages: 2072–2081, Markku Korpela, Leena Laasonen, Pekka Hannonen, Hannu Kautiainen, Marjatta Leirisalo-Repo, Markku Hakala, Leena Paimela, Harri Blåfield, Kari Puolakka and Timo Möttönen

    Version of Record online : 6 JUL 2004, DOI: 10.1002/art.20351

  15. You have free access to this content
    Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations

    Arthritis & Rheumatism

    Volume 64, Issue 3, March 2012, Pages: 630–638, Leslie R. Harrold, J. Timothy Harrington, Jeffrey R. Curtis, Daniel E. Furst, Mary Jane Bentley, Ying Shan, George Reed, Joel Kremer and Jeffrey D. Greenberg

    Version of Record online : 28 FEB 2012, DOI: 10.1002/art.33380

  16. You have free access to this content
    Changes in Use of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States During 1983–2009

    Arthritis Care & Research

    Volume 65, Issue 9, September 2013, Pages: 1529–1533, Seoyoung C. Kim, Ed Yelin, Chris Tonner and Daniel H. Solomon

    Version of Record online : 26 AUG 2013, DOI: 10.1002/acr.21997

  17. Abatacept for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Lara Maxwell and Jasvinder A Singh

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD007277.pub2

  18. You have free access to this content
    Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis

    Arthritis Care & Research

    Volume 55, Issue 6, 15 December 2006, Pages: 864–872, Axel Finckh, Matthew H. Liang, Carmen Mugica van Herckenrode and Paola de Pablo

    Version of Record online : 30 NOV 2006, DOI: 10.1002/art.22353

  19. You have free access to this content
    Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia

    Arthritis Care & Research

    Volume 64, Issue 11, November 2012, Pages: 1730–1738, Kristin Palmsten, Sonia Hernández-Díaz, Bindee Kuriya, Daniel H. Solomon and Soko Setoguchi

    Version of Record online : 30 OCT 2012, DOI: 10.1002/acr.21807

  20. You have free access to this content
    Tocilizumab as monotherapy or in combination with nonbiologic disease-modifying antirheumatic drugs: Twenty-four–week results of an open-label, clinical practice study

    Arthritis Care & Research

    Volume 65, Issue 3, March 2013, Pages: 362–371, Michael E. Weinblatt, Joel Kremer, John Cush, William Rigby, Lichen L. Teng, Jenny Devenport, Natasha Singh, Denise Lepley and Mark C. Genovese

    Version of Record online : 26 FEB 2013, DOI: 10.1002/acr.21847